1h Free Analyst Time
Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Merck & Co Inc (Merck) is a biopharmaceutical company focused on the discovery, development, manufacturing and marketing of prescription medicines, biologic therapies, vaccines, and animal health products. It offers prescription products for therapy areas related to cardiovascular, cancer, immune disorders, infectious, respiratory, and diabetes. The company provides animal health products such as vaccines, poultry products, livestock products and aquaculture products. Merck sells medicines to drug wholesalers, retailers, hospitals, government agencies and managed health care providers; and animal health products to veterinarians, distributors and animal producers. The company and its subsidiaries operate in the Americas, Europe, the Middle East, Africa, Asia Pacific, and Latin America. Merck is known as MSD outside the US and Canada and is headquartered in Kenilworth, New Jersey, the US.Merck & Co Inc Key Recent Developments
- Apr 13, 2023: Microbiotica, MSD partner to start melanoma combo therapy trial
- Mar 30, 2023: Merck to Hold First-Quarter 2023 Sales and Earnings Conference Call on April 27
- Mar 14, 2023: Greenphire, Merck expand agreement to minimise barriers for trial subjects
- Mar 09, 2023: ModeX Therapeutics and Merck sign deal for Epstein-Barr Virus vaccine
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Bristol-Myers Squibb Co
- Adamas Pharmaceuticals Inc
- AstraZeneca Plc
- Johnson & Johnson
- SELLAS Life Sciences Group Inc
- Novartis AG
- GSK plc
- Incyte Corp
- Takeda Pharmaceutical Co Ltd
- Curis Inc
- Eli Lilly and Co
- Hester Biosciences Ltd
- Pfizer Inc
- AbbVie Inc
- Amgen Inc
- Sanofi
- Eli Lilly and Co
- GSK plc
- Hester Biosciences Ltd
- Incyte Corp
- Pfizer Inc
- Takeda Pharmaceutical Co Ltd
- Johnson & Johnson
- Curis Inc
- Novartis AG
- AbbVie Inc
- Sanofi
- Amgen Inc
- AstraZeneca Plc
- Adamas Pharmaceuticals Inc
- SELLAS Life Sciences Group Inc
- Bristol-Myers Squibb Co